Soleimani Ali-Reza, Akbari Hossein, Soleimani Saeid, Beladi Mousavi Seyed Seifollah, Tamadon Mohamad-Reza
Department of Internal Diseases, Kashan University of Medical Sciences, Kashan, Iran.
Department of Statistics, Kashan University of Medical Sciences, Kashan, Iran.
J Renal Inj Prev. 2015 Sep 1;4(3):73-9. doi: 10.12861/jrip.2015.15. eCollection 2015.
Herbal medicines are traditionally prescribed to manage blood pressure.
We aimed to evaluate effect of sour tea pill containing the herb's extract versus captopril on the treatment of hypertension.
In our crossover clinical trial 20 patients were enrolled in the study and advised for life style modification then the participants were randomly divided into 2 groups. Sour tea pills was prescribed at a dose of 500 mg and captopril at a dose of 12.5 mg twice daily. In order to improve precision and final measurement, ambulatory blood pressure monitoring (ABPM) was performed both prior and after measuring the hypertension in 2 successive visits. After 6 weeks of therapy, the methods changed and 6 weeks later ABPM was performed three times (baseline, at end of the 6th and 12th week). The 2 groups were merged together before data analysis.
Of the 20 patients, 13 (65%) were male and 7 (35%) were female. No significant difference of sex, age, and job was detected between 2 groups (P ≥ 0.05). Mean decreasing in systolic blood pressure was 7.75 ± 8.3 and 13.3 ± 16.1 mm Hg in the captopril and sour tea groups, respectively. Also, mean decline in diastolic blood pressure decreases was 2.15 ± 4.14 and 5.8 ± 7.8 mm Hg for captopril and sour tea groups, respectively. No side effect was observed in the sour tea pill group in the study.
According to the effect of sour tea pill on decreasing blood pressure, without giving priority over captopril, sour tea pill containing the herb's extract can be prescribed as an adjuvant therapy for lowering the prescribed dosage of captopril.
传统上会开草药来控制血压。
我们旨在评估含该草药提取物的酸茶丸与卡托普利治疗高血压的效果。
在我们的交叉临床试验中,20名患者参与研究并接受生活方式调整建议,然后将参与者随机分为两组。酸茶丸的给药剂量为500毫克,卡托普利的给药剂量为12.5毫克,每日两次。为提高精确度和最终测量结果,在连续两次就诊测量高血压前后均进行动态血压监测(ABPM)。治疗6周后,方法改变,6周后进行三次ABPM(基线、第6周和第12周结束时)。在数据分析前将两组合并在一起。
20名患者中,13名(65%)为男性,7名(35%)为女性。两组之间在性别、年龄和工作方面未检测到显著差异(P≥0.05)。卡托普利组和酸茶组收缩压的平均下降分别为7.75±8.3和13.3±16.1毫米汞柱。此外,卡托普利组和酸茶组舒张压的平均下降分别为2.15±4.14和5.8±7.8毫米汞柱。研究中酸茶丸组未观察到副作用。
根据酸茶丸对降低血压的效果,在不优于卡托普利的情况下,含该草药提取物的酸茶丸可作为辅助治疗药物,以降低卡托普利的规定剂量。